Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Piramal Pharma Limited
PPLPHARMACurrent price
227.7 INR
-4.97 INR (-2.14%)
Last closed
232.67 INR
Company
www.piramalpharma.com
ISIN
INE0DK501011
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
301 245 886 077 INR
Yield for 12 month
+125.33 %
1Y
3Y
5Y
10Y
15Y
PPLPHARMA
Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India. Address: Piramal Ananta, Mumbai, India, 400 070
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
844.8518Dividend Yield
0.05 %Current Year
+81 699 023 932 INR
Last Year
+70 804 600 929 INR
Current Quarter
+19 508 397 015 INR
Last Quarter
+25 519 671 706 INR
Current Year
+24 467 133 731 INR
Last Year
+43 775 761 538 INR
Current Quarter
+5 124 511 173 INR
Last Quarter
+8 475 595 365 INR
Key Figures PPLPHARMA
1 year
3 years
5 years
10 years
EBITDA
12 146 605 138 INR
Operating Margin TTM
PE Ratio
844.8518
Return On Assets TTM
1.93 %
PEG Ratio
–
Return On Equity TTM
0.24 %
Wall Street Target Price
–
Revenue TTM
83 721 616 033 INR
Book Value
59.79 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
11.6 %
Dividend Yield
0.05 %
Gross Profit TTM
41 707 579 891 INR
Earnings per share
0.27 INR
Diluted Eps TTM
0.27 INR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
83.3 %
Profit Margin
0.33 %
Dividend Analytics PPLPHARMA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PPLPHARMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.11
Ex Dividend Date
12.07.2024
Forward Annual Dividend Yield
0.05 %
Last Split Factor
–
Payout Ratio
8.21 %
Last Split Date
–
Dividend Date
–
Stock Valuation PPLPHARMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
844.8518
Forward PE
–
Enterprise Value Revenue
4.122
Price Sales TTM
3.5982
Enterprise Value EBITDA
23.9799
Price Book MRQ
3.8083
Financials PPLPHARMA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PPLPHARMA
For 52 weeks
87.42 INR
243.95 INR
50 Day MA
180.92 INR
Shares Short Prior Month
–
200 Day MA
150.73 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart